Page 11 - Read Online
P. 11

Page 761                  Gmeiner et al. Cancer Drug Resist 2021;4:758-61  https://dx.doi.org/10.20517/cdr.2021.65

               Conflicts of interest
               Both authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2021.


               REFERENCES
               1.       Champoux JJ. DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 2001;70:369-413.  DOI  PubMed
               2.       Gmeiner WH, Dominijanni A, Haber AO, et al. Improved antitumor activity of the fluoropyrimidine polymer CF10 in preclinical
                   colorectal cancer models through distinct mechanistic and pharmacologic properties. Mol Cancer Ther 2021;20:553-63.  DOI  PubMed
                   PMC
               3.       Lotz C, Lamour V. The interplay between DNA topoisomerase 2α post-translational modifications and drug resistance. Cancer Drug
                   Resist 2020;3:149-60.  DOI
               4.       Elton TS, Ozer HG, Yalowich JC. Effects of DNA topoisomerase IIα splice variants on acquired drug resistance. Cancer Drug Resist
                   2020;3:161-70.  DOI  PubMed  PMC
               5.       Soren BC, Dasari JB, Ottaviani A, Iacovelli F, Fiorani P. Topoisomerase IB: a relaxing enzyme for stressed DNA. Cancer Drug Resist
                   2020;3:18-25.  DOI
               6.       Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. Plant antitumor agents. I. The isolation and structure of
                   camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata. J Am Chem Soc 1966;88:3888-90.  DOI
               7.       Gmeiner WH. Entrapment of DNA topoisomerase-DNA complexes by nucleotide/nucleoside analogs. Cancer Drug Resist
                   2019;2:994-1001.  DOI  PubMed  PMC
               8.       Wang JC. Interaction between DNA and an Escherichia coli protein omega. J Mol Biol 1971;55:523-33.  DOI  PubMed
               9.       Yang SW, Burgin AB Jr, Huizenga BN, Robertson CA, Yao KC, Nash HA. A eukaryotic enzyme that can disjoin dead-end covalent
                   complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A 1996;93:11534-9.  DOI  PubMed  PMC
               10.      Brettrager EJ, van Waardenburg RCAM. Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked
                   DNA-adducts. Cancer Drug Resist 2019;2:1153-63.  DOI  PubMed  PMC
   6   7   8   9   10   11   12   13   14   15   16